B
BioClonal specializes in the design and customization of monoclonal antibodies for therapeutic applications, utilizing advanced immunogen design and immunization techniques to enhance antibody discovery. The company addresses the inefficiencies of traditional immunization methods, enabling the development of effective therapies for oncology and immunology.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- BioClonal specializes in the design and customization of monoclonal antibodies for therapeutic applications, utilizing advanced immunogen design and immunization techniques to enhance antibody discovery. The company addresses the inefficiencies of traditional immunization methods, enabling the development of effective therapies for oncology and immunology.